StockData
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

REGENTIS BIOMATERIALS LTD.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$1.48−0.01 (-0.67%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

21 of Regentis Biomaterials's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KOct 13, 2026Oct 13, 2026SEC EDGAR
Current report6-KJun 30, 2026Sep 11, 2026SEC EDGAR
Current report6-KJul 20, 2026Jul 20, 2026SEC EDGAR
Current report6-KJul 15, 2026Jul 15, 2026SEC EDGAR
Current report6-KJul 9, 2026Jul 9, 2026SEC EDGAR
Current report6-KJul 2, 2026Jul 2, 2026SEC EDGAR
Current report6-KJun 18, 2026Jun 18, 2026SEC EDGAR
Current report6-KJun 15, 2026Jun 15, 2026SEC EDGAR
Current report6-KJun 8, 2026Jun 8, 2026SEC EDGAR
Current report6-KMay 28, 2026May 28, 2026SEC EDGAR
Annual report, amended20-F/ADec 31, 2025Feb 27, 2026SEC EDGAR
Annual report20-FDec 31, 2025Feb 24, 2026SEC EDGAR
Current report6-KFeb 24, 2026Feb 24, 2026SEC EDGAR
Current report6-KFeb 17, 2026Feb 17, 2026SEC EDGAR
Current report6-KFeb 5, 2026Feb 5, 2026SEC EDGAR
Current report6-KJan 29, 2026Jan 29, 2026SEC EDGAR
Current report6-KJan 20, 2026Jan 20, 2026SEC EDGAR
Current report6-KJan 6, 2026Jan 6, 2026SEC EDGAR
Current report6-KJan 6, 2026Jan 6, 2026SEC EDGAR
Current report6-KDec 18, 2025Dec 18, 2025SEC EDGAR
Current report6-KDec 5, 2025Dec 5, 2025SEC EDGAR